185 related articles for article (PubMed ID: 20171660)
21. Editorial comment.
Haas GP
Urology; 2010 Feb; 75(2):270. PubMed ID: 20152476
[No Abstract] [Full Text] [Related]
22. Editorial comment.
Maranchie JK
J Urol; 2010 Feb; 183(2):492. PubMed ID: 20006863
[No Abstract] [Full Text] [Related]
23. Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications.
Leibovitch I; Lev R; Mor Y; Golomb J; Dotan ZA; Ramon J
Isr Med Assoc J; 2001 Aug; 3(8):563-5. PubMed ID: 11519377
[TBL] [Abstract][Full Text] [Related]
24. Editorial comment.
Russo P
Urology; 2011 Apr; 77(4):847-8. PubMed ID: 21477710
[No Abstract] [Full Text] [Related]
25. Editorial comment to effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.
Gudbjartsson T
Int J Urol; 2013 Jun; 20(6):579. PubMed ID: 23621609
[No Abstract] [Full Text] [Related]
26. Editorial comment.
Weight CJ
Urology; 2009 Nov; 74(5):1068-9. PubMed ID: 19883823
[No Abstract] [Full Text] [Related]
27. Renal cell carcinomata with slow growth and prolonged survival.
Haddad FS
J Med Liban; 1999; 47(3):201-4. PubMed ID: 10550948
[TBL] [Abstract][Full Text] [Related]
28. The role of radical nephrectomy in metastatic renal cell carcinoma.
Flanigan RC; Yonover PM
Semin Urol Oncol; 2001 May; 19(2):98-102. PubMed ID: 11354539
[TBL] [Abstract][Full Text] [Related]
29. Editorial comment on: prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.
Ohlmann CH
Eur Urol; 2010 Feb; 57(2):325-6. PubMed ID: 19136198
[No Abstract] [Full Text] [Related]
30. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
Pantuck AJ
Eur Urol; 2007 Oct; 52(4):1145-6. PubMed ID: 17336450
[No Abstract] [Full Text] [Related]
31. Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
van der Kwast TH
Eur Urol; 2007 Oct; 52(4):1146. PubMed ID: 17336448
[No Abstract] [Full Text] [Related]
32. Editorial comment on: Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
Bex A
Eur Urol; 2007 Nov; 52(5):1436-7. PubMed ID: 17420089
[No Abstract] [Full Text] [Related]
33. [Pathology of benign and malignant renal cell tumors].
Thoenes W; Störkel S
Urologe A; 1991 Nov; 30(6):W41-50. PubMed ID: 1771712
[No Abstract] [Full Text] [Related]
34. Conservative surgery of kidney tumors.
Selli C; Lapini A; Carini M
Prog Clin Biol Res; 1991; 370():9-17. PubMed ID: 1924484
[No Abstract] [Full Text] [Related]
35. Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Staehler M
Eur Urol; 2007 Oct; 52(4):1155. PubMed ID: 17287072
[No Abstract] [Full Text] [Related]
36. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
[TBL] [Abstract][Full Text] [Related]
37. High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
[No Abstract] [Full Text] [Related]
38. [Kidney parenchyma carcinoma--diagnosis. German Society of Urology].
Urologe A; 1998 May; 37(3):328-41. PubMed ID: 9646432
[No Abstract] [Full Text] [Related]
39. Editorial comment.
Shichman SJ
Urology; 2010 Feb; 75(2):281. PubMed ID: 20152480
[No Abstract] [Full Text] [Related]
40. Editorial comment.
Lane BR; Campbell SC
Urology; 2010 Feb; 75(2):281. PubMed ID: 20152479
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
